Response to: lower‐dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 625-626

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 934-0874, Iss. 11, 2015-11 ,pp. : 1332-1335

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 11, 2015-11 ,pp. : 1332-1335

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytotoxic T‐lymphocyte therapy for post‐transplant lymphoproliferative disorder after solid organ transplantation in children

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diarrhea in solid-organ transplant recipients: a review of the evidence

By Pant Chaitanya   Deshpande Abhishek   Larson Anne   O’Connor Judith   Rolston David D.K.   Sferra Thomas J.  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1315-1328

Informa Healthcare

Access to resources Recommend Favorite